Pakistan's first CAR-T cell therapy marks cancer milestone

A schematic diagram illustrating the steps of CAR T-cell therapy. — CONTEXTUAL ILLUSTRATION A schematic showing the steps of CAR T-cell therapy, in which a patient's T cells are genetically modified to attack cancer cells. It is a file illustration and does not depict the procedure performed in Pakistan. Image: National Cancer Institute, via Wikimedia Commons, public domain.

What happened

Pakistan has carried out its first CAR-T cell therapy, an advanced form of cancer immunotherapy, at the Armed Forces Bone Marrow Transplant Centre. The procedure was performed by specialists from the Army Medical Corps after years of research, planning and technical preparation, according to a report by Daily Pakistan.

The first recipient, a 21-year-old cancer patient, is recovering after the treatment. Medical staff involved in the case praised the patient’s courage and the family’s support through the process.

What the therapy involves

CAR-T cell therapy uses a patient’s own immune cells. T cells are collected from the patient, genetically reprogrammed in a laboratory to recognise and attack cancer cells, and then infused back into the body. The personalised approach has improved outcomes for some hard-to-treat blood cancers where other options are limited.

Why it matters

Successfully delivering the treatment places Pakistan among a small group of countries able to offer the therapy, according to the report. Health professionals cited by the outlet said the milestone could encourage investment in medical research and widen access to advanced cancer care for patients who currently have to seek treatment abroad. For families facing blood cancers, the development offers the prospect of world-class care closer to home.